REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431 | +8.8% | 15,587 | +5.3% | 0.00% | +33.3% |
| Q2 2023 | $396 | +89.5% | 14,800 | +53.4% | 0.00% | +50.0% |
| Q1 2023 | $209 | -13.6% | 9,649 | -4.9% | 0.00% | 0.0% |
| Q4 2022 | $242 | -99.9% | 10,146 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $197,000 | +21.6% | 9,965 | +20.2% | 0.00% | 0.0% |
| Q2 2022 | $162,000 | -15.6% | 8,292 | +10.2% | 0.00% | +100.0% |
| Q1 2022 | $192,000 | -52.9% | 7,522 | -53.5% | 0.00% | -50.0% |
| Q4 2021 | $408,000 | +81.3% | 16,176 | +97.6% | 0.00% | 0.0% |
| Q3 2021 | $225,000 | -19.1% | 8,187 | -6.4% | 0.00% | 0.0% |
| Q2 2021 | $278,000 | -0.4% | 8,748 | +44.0% | 0.00% | -80.0% |
| Q1 2021 | $279,000 | +16.7% | 6,075 | +0.7% | 0.01% | +11.1% |
| Q4 2020 | $239,000 | +14.4% | 6,031 | +0.6% | 0.01% | 0.0% |
| Q3 2020 | $209,000 | – | 5,998 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |